BORTEZOMIB TEVA 1 MG

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

BORTEZOMIB

Dostupno od:

ABIC MARKETING LTD, ISRAEL

ATC koda:

L01XX32

Farmaceutski oblik:

POWDER FOR SOLUTION FOR INJECTION

Sastav:

BORTEZOMIB 1 MG

Administracija rute:

I.V

Tip recepta:

Required

Proizveden od:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Područje terapije:

BORTEZOMIB

Terapijske indikacije:

Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

Datum autorizacije:

2017-07-04